BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 27144175)

  • 1. Analyzing Dynamic Changes of Laboratory Indexes in Patients with Acute Heart Failure Based on Retrospective Study.
    Wang Y; Fu L; Jia Q; Yu H; Zhang P; Zhang C; Huang X; He K; Tian Y
    Biomed Res Int; 2016; 2016():7496061. PubMed ID: 27144175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of C-reactive protein as an inflammatory and N-terminal probrain natriuretic peptide as a neurohumoral marker in acute heart failure (from the Korean Heart Failure registry).
    Park JJ; Choi DJ; Yoon CH; Oh IY; Jeon ES; Kim JJ; Cho MC; Chae SC; Ryu KH; Yoo BS; Kang SM; Oh BH;
    Am J Cardiol; 2014 Feb; 113(3):511-7. PubMed ID: 24315115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T.
    Metra M; Nodari S; Parrinello G; Specchia C; Brentana L; Rocca P; Fracassi F; Bordonali T; Milani P; Danesi R; Verzura G; Chiari E; Dei Cas L
    Eur J Heart Fail; 2007 Aug; 9(8):776-86. PubMed ID: 17573240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure.
    Aimo A; Januzzi JL; Mueller C; Mirò O; Pascual Figal DA; Jacob J; Herrero-Puente P; Llorens P; Wussler D; Kozhuharov N; Sabti Z; Breidthardt T; Vergaro G; Ripoli A; Prontera C; Saccaro L; Passino C; Emdin M
    Int J Cardiol; 2019 Oct; 293():137-142. PubMed ID: 31200964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ischemic biomarker heart-type fatty acid binding protein (hFABP) in acute heart failure - diagnostic and prognostic insights compared to NT-proBNP and troponin I.
    Hoffmann U; Espeter F; Weiß C; Ahmad-Nejad P; Lang S; Brueckmann M; Akin I; Neumaier M; Borggrefe M; Behnes M
    BMC Cardiovasc Disord; 2015 Jun; 15():50. PubMed ID: 26072112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of decrease in plasma N-terminal pro-brain natriuretic peptide identifies acute heart failure patients with very poor outcome.
    Kubler P; Jankowska EA; Majda J; Reczuch K; Banasiak W; Ponikowski P
    Int J Cardiol; 2008 Oct; 129(3):373-8. PubMed ID: 18054808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk stratification with the use of serial N-terminal pro-B-type natriuretic peptide measurements during admission and early after discharge in heart failure patients: post hoc analysis of the PRIMA study.
    Eurlings LW; Sanders-van Wijk S; van Kraaij DJ; van Kimmenade R; Meeder JG; Kamp O; van Dieijen-Visser MP; Tijssen JG; Brunner-La Rocca HP; Pinto YM
    J Card Fail; 2014 Dec; 20(12):881-90. PubMed ID: 25175696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
    de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
    Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between cardiac, renal, and hepatic biomarkers and outcomes in patients with acute heart failure.
    Chan WW; Waltman Johnson K; Friedman HS; Navaratnam P
    Hosp Pract (1995); 2016 Aug; 44(3):138-45. PubMed ID: 27292609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term serial kinetics of N-terminal pro B-type natriuretic peptide and carbohydrate antigen 125 for mortality risk prediction following acute heart failure.
    Núñez J; Núñez E; Bayés-Genís A; Fonarow GC; Miñana G; Bodí V; Pascual-Figal D; Santas E; Garcia-Blas S; Chorro FJ; Rizopoulos D; Sanchis J
    Eur Heart J Acute Cardiovasc Care; 2017 Dec; 6(8):685-696. PubMed ID: 27199489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma N-terminal pro-B-type natriuretic peptide as a predictor of perioperative and long-term outcome after vascular surgery.
    Schouten O; Hoeks SE; Goei D; Bax JJ; Verhagen HJ; Poldermans D
    J Vasc Surg; 2009 Feb; 49(2):435-41; discussion 441-2. PubMed ID: 19028043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of prognostic value of red cell distribution width and NT-proBNP for short-term clinical outcomes in acute heart failure patients.
    He W; Jia J; Chen J; Qin S; Tao H; Kong Q; Xue Q; Zhang D
    Int Heart J; 2014; 55(1):58-64. PubMed ID: 24463920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term mortality risk in emergency department acute heart failure.
    Peacock WF; Nowak R; Christenson R; DiSomma S; Neath SX; Hartmann O; Mueller C; Ponikowski P; Möckel M; Hogan C; Wu AH; Richards M; Filippatos GS; Anand I; Ng LL; Daniels LB; Morgenthaler N; Anker SD; Maisel AS
    Acad Emerg Med; 2011 Sep; 18(9):947-58. PubMed ID: 21906204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of discharge haemoglobin and NT-proBNP to improve short and long-term outcome prediction in patients with acute heart failure.
    Stojcevski B; Celic V; Navarin S; Pencic B; Majstorovic A; Sljivic A; Magrini L; Cristofano F; Cavalieri L; Di Somma S;
    Eur Heart J Acute Cardiovasc Care; 2017 Dec; 6(8):676-684. PubMed ID: 25943556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ELAN-HF Score.
    Salah K; Kok WE; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Bayes-Genis A; Verdiani V; Bettari L; Lazzarini V; Damman P; Tijssen JG; Pinto YM
    Heart; 2014 Jan; 100(2):115-25. PubMed ID: 24179162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple biomarker strategy for improved diagnosis of acute heart failure in older patients presenting to the emergency department.
    Bahrmann P; Bahrmann A; Hofner B; Christ M; Achenbach S; Sieber CC; Bertsch T
    Eur Heart J Acute Cardiovasc Care; 2015 Apr; 4(2):137-47. PubMed ID: 25002708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes.
    Heeschen C; Hamm CW; Mitrovic V; Lantelme NH; White HD;
    Circulation; 2004 Nov; 110(20):3206-12. PubMed ID: 15533869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission.
    Weber M; Bazzino O; Navarro Estrada JL; Fuselli JJ; Botto F; Perez de Arenaza D; Möllmann H; Nef HN; Elsässer A; Hamm CW
    J Am Coll Cardiol; 2008 Mar; 51(12):1188-95. PubMed ID: 18355657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction.
    Santhanakrishnan R; Chong JP; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong R; Chai P; Low AF; Richards AM; Lam CS
    Eur J Heart Fail; 2012 Dec; 14(12):1338-47. PubMed ID: 22869458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trial.
    Demissei BG; Cotter G; Prescott MF; Felker GM; Filippatos G; Greenberg BH; Pang PS; Ponikowski P; Severin TM; Wang Y; Qian M; Teerlink JR; Metra M; Davison BA; Voors AA
    Eur J Heart Fail; 2017 Aug; 19(8):1001-1010. PubMed ID: 28133908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.